Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001753926-25-000509
Filing Date
2025-03-28
Accepted
2025-03-28 06:21:40
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 g084740_s3.htm S-3 422777
2 EXHIBIT 5.1 g084740_ex5-1.htm EX-5.1 21772
3 EXHIBIT 23.1 g084740_ex23-1.htm EX-23.1 4273
4 EXHIBIT 107 g084740_ex107.htm EX-FILING FEES 26840
5 GRAPHIC image_001.jpg GRAPHIC 6208
6 GRAPHIC img001.jpg GRAPHIC 16056
  Complete submission text file 0001753926-25-000509.txt   507722
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC. (Filer) CIK: 0001347242 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-286199 | Film No.: 25781337
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)